George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.50
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 0.50 (2.857%)
Open: 17.75
High: 17.75
Low: 17.75
Prev. Close: 17.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix Health signs North America manufacturing deal with Agropur

Mon, 24th Jun 2019 07:43

(Sharecast News) - OptiBiotix Health has entered into a manufacturing, supply and distribution agreement with Agropur, it announced on Monday.The AIM-traded firm said the agreement granted Agropur an exclusive license to manufacture, supply and distribute OptiBiotix's 'SlimBiome' weight management technology in the United States, Canada and Mexico.It described Agropur, founded in 1938, as a North American "dairy industry leader" with 8,800 employees and sales of $6.7bn in 2018.It processed more than 6.2 billion litres of milk per year at its 39 plants across North America, and boasted a portfolio of brands and products including Natrel, OKA, Iögo, BiPRO, Agropur Grand Cheddar, Olympic, Farmers, Island Farms, Québon, ISO Chill and Crino.SlimBiome, meanwhile, was OptiBiotix's flagship weight management product, which would be supplied by Agropur's Customs Solutions Group as a specialised functional ingredient.It could be incorporated into a wide range of applications, including human nutrition comprising of food and beverages, dairy, dietary supplements and sports nutrition, with the exception of extruded product in cereal particulates which is a market segment serviced by Cereal Ingredients.OptiBiotix said the deal was a "strategic step" to de-risk its supply chain and extend the market reach of SlimBiome, by adding manufacturing in North America.It said it would extend the commercial opportunity for its patented weight management product into the US weight management market, which was estimated to be worth $72bn in 2019.The company said partnering with an established player with an extensive reach to companies using high-value functional ingredients into their food applications would allow end users to reduce transport and tariff costs, while shortening lead-times and granting them access to Agropur's expert advice and capabilities to create value."We are pleased to announce the signing of a manufacturing and supply agreement with Agropur," said Dr Fred Narbel, the managing director of OptiBiotix's prebiotics division."We chose Agropur due to their world leading expertise in manufacturing and distributing specialty ingredients like SlimBiome® and their reputation for supplying high quality products to the food industry."We believe working with Agropur, and similar partners around the world, provides the best opportunity of increasing our global commercial reach and catering to the growing interest we are seeing in SlimBiome® from partners worldwide."Mike Homewood, vice-president of Agropur's Custom Solutions Group, added that the collaboration with OptiBiotix Health was "well-aligned" with his company's goal to bring innovation to its customers."The manufacturing and supply of SlimBiome is a natural fit within our model of solution-focused ingredients for the food, beverage and nutrition industries. We look forward to collaborating with OptiBiotix Health in the North American market."
More News
5 Jan 2021 17:55

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

Read more
9 Dec 2020 16:08

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

Read more
18 Nov 2020 14:53

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

Read more
18 Nov 2020 12:23

OptiBiotix grants LPLDL licence to Canada's Genuine Health

(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has granted a non-exclusive licence for 'LPLDL' to Genuine Health, for a cardiovascular health product in Canada and the United States.

Read more
12 Oct 2020 14:34

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

Read more
12 Oct 2020 14:00

OptiBiotix products launch into retail in Australia, New Zealand

(Sharecast News) - Life sciences company OptiBiotix Health announced the launch of meal replacement shakes and bars containing its 'OptiBiome' proprietary weight management technology under the 'Optislim' brand with the Woolworths and Chemist Warehouse retailers, and online, in Australia and New Zealand.

Read more
8 Oct 2020 21:16

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

Read more
6 Oct 2020 14:36

IN BRIEF: OptiBiotix's ProBiotix Inks Singaporean Deal For CholBiomeX3

IN BRIEF: OptiBiotix's ProBiotix Inks Singaporean Deal For CholBiomeX3

Read more
2 Oct 2020 11:13

OptiBiotix Notes FDA Approval For Investigation Into Partner's New Drug

OptiBiotix Notes FDA Approval For Investigation Into Partner's New Drug

Read more
2 Oct 2020 10:17

OptiBiotix shares rise as partner Seed gets FDA approval

(Sharecast News) - Life sciences company OptiBiotix Health announced on Friday that one of its partners, Seed Health, has received US Food and Drug Administration authorisation for an investigational new drug (IND) application for 'DS-01'.

Read more
24 Sep 2020 12:25

OptiBiotix revenue improves fivefold in first half

(Sharecast News) - Life sciences company OptiBiotix Health reported first-half revenue growth to £0.74m in its first half on Thursday, which was a five times increase in revenues from the first half of 2019.

Read more
24 Sep 2020 12:04

IN BRIEF: OptiBiotix Pretax Loss Narrows, Prepares For Dual Listing

IN BRIEF: OptiBiotix Pretax Loss Narrows, Prepares For Dual Listing

Read more
22 Sep 2020 15:04

IN BRIEF: OptiBiotix Inks SlimBiome License Deal With HiLife Vitamins

IN BRIEF: OptiBiotix Inks SlimBiome License Deal With HiLife Vitamins

Read more
22 Sep 2020 10:05

OptiBiotix enters new licensing deal with HiLife Vitamins

(Sharecast News) - Life sciences company OptiBiotix Health has entered into a non-exclusive license agreement for 'SlimBiome Medical' with HiLife Vitamins & Herbs, it announced on Tuesday.

Read more
17 Sep 2020 17:05

IN BRIEF: OptiBiotix Signs Distribution Deal For LPLDL In Brazil

IN BRIEF: OptiBiotix Signs Distribution Deal For LPLDL In Brazil

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.